Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Leukemia & Lymphoma|February 1, 1997
A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin's lymphomaA Engert, R Schnell, F Küpper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2002
Phase II and pharmacologic study of weekly oral paclitaxel plus cyclosporine in patients with advanced non-small-cell lung cancerC M F Kruijtzer, J H M Schellens, J Mezger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumorsA Korfel, M E Scheulen, H J Schmoll, et al.
British Journal of Cancer|January 18, 2014
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumorsS Bauer, R A Hilger, T Mühlenberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2006
Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumorsH Richly, B F Henning, P Kupsch, et al.
Bone Marrow Transplantation|December 14, 2004
Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complicationsD W Beelen, R Trenschel, J Casper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumorsK Mross, H Richly, N Schleucher, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIVL Bergmann, L Maute, G Heil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000
Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignanciesM E Scheulen, R A Hilger, C Oberhoff, et al.
Pageof 7